NCT07047482 Clinicopathological Value of p16 Expression in Colorectal Carcinoma
| NCT ID | NCT07047482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Colorectal Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-03-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-05-01 with a primary completion date of 2026-03-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of the immunohistochemical expression of p16 in colorectal carcinoma and correlate its expression to different clinical and pathological parameters as patients' ages, sexes, tumor location, histopathological phenotype, status of nodal involvement, perineural and lymphovascular invasion.
Eligibility Criteria
Inclusion Criteria: 1. Specimens from patients with colorectal cancer. 2. Tissue blocks with sufficient material. 3. Specimens with sufficient clinical data. Exclusion Criteria: 1. Tissue blocks with insufficient, destroyed or necrotic material. 2. Specimens with insufficient clinical data.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07047482 clinical trial?
This trial is open to participants of all sexes, studying Colorectal Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07047482 currently recruiting?
Yes, NCT07047482 is actively recruiting participants. Contact the research team at shery.raoof@med.sohag.edu.eg for enrollment information.
Where is the NCT07047482 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07047482 clinical trial?
NCT07047482 is sponsored by Sohag University. The trial plans to enroll 50 participants.